TEYI PHARMACEUTICA revenue for the last year amounted to 1.07 B CNY, the most of which — 582.39 M CNY — came from its highest performing source at the moment, Chinese Patent Medicine, the year earlier bringing 404.26 M CNY. The greatest contribution to the revenue figure was made by China — last year it brought TEYI PHARMACEUTICA 1.07 B CNY, and the year before that — 885.67 M CNY.